Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 1

3438 - High-biologically effective dose radiotherapy improve the survival of small cell lung cancer patients with brain metastases: a propensity-matching analysis


28 Sep 2019


Poster Display session 1


Tumour Site

Small Cell Lung Cancer


Qingyang Zhuang


Annals of Oncology (2019) 30 (suppl_5): v710-v717. 10.1093/annonc/mdz264


Q. Zhuang1, F. Lin1, X. Lin1, X. Zhang1, Y. Huang1, L. Tang1, J. Li2, J. Wu1

Author affiliations

  • 1 Radiation Oncology, Fujian Medical University Cancer Hospital, 350014 - Fuzhou/CN
  • 2 Radiation Oncology, Xiamen Cancer Hospital, 361001 - Xiamen/CN


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 3438


To compare the effects of high biologically effective dose (BED) and low BED radiotherapy for small cell lung cancer (SCLC) with brain metastases (BMs), and identify the prognostic factors of survival.


A total of 250 consecutive SCLC (stage II-IV) with BMs patients in our institution were retrospectively analyzed, from January 1998 to June 2018. Preliminary screening of the prognostic factors was accomplished by Kaplan-Meier univariate analysis. Baseline covariates were balanced by a propensity score model. And survival curves between the two groups were compared by the log-rank test. The Cox regression model was used to analyze factors associated with prognosis.


The Cutoff Finder program exported an optimal BED cutoff value of 47 for all patients. The high-BED (>47 Gy) group had a significantly better OS than low-BED (≤47 Gy) group (median OS: 17.5 vs. 9.5, P < 0.001). Multivariate analysis found that BED (P < 0.001), smoking (P = 0.017), ECOG score (P = 0.047) and age (P = 0.004) were independently prognostic factors affecting OS. And after 1:2 propensity score matching, 163 patients were divided into the high-BED group (n = 57) and the low-BED group (n = 106). In the matched cohort, OS was significantly higher in the high-BED group than low-BED group (P < 0.001).


BED, smoking, ECOG score, age were observed to affect the OS of SCLC patients with BMs. High BED radiotherapy (>47 Gy) might improve long-term survival.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Qingyang, Zhuang.


The Fujian Province Natural Science Foundation (2017J01260), Joint Funds for the Innovation of Science and Technology, Fujian province (2017Y9074), and the Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing (2017 Open Project-9).


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.